The C15orf40 Knockout SK-HEP-1 Polyclonal Cells are a heterogeneous population of human SK-HEP-1 liver adenocarcinoma cells that have undergone CRISPR/Cas9-mediated gene disruption at the C15orf40 locus. This polyclonal knockout product is generated by delivering a ribonucleoprotein complex to induce targeted mutations, yielding a mixed culture that encompasses a spectrum of editing events. As a polyclonal population, it avoids the bottleneck of clonal isolation, providing a robust loss-of-function model that captures the collective phenotypic variability of the edited pool. Such a design is particularly suited for high-throughput screening and functional assays requiring consistent representation of knockout effects.
The parental SK-HEP-1 cell line is derived from human liver adenocarcinoma and is a well-established model in hepatocellular carcinoma research. Originating from ascetic fluid, these epithelial cells are valuable for studying liver cancer biology, including proliferation, metastasis, and drug resistance. Their tumorigenic capacity in xenograft models underscores their relevance for in vivo translation; the cell line’s well-characterized profile supports robust experimental reproducibility. Utilizing this background for C15orf40 knockout enables the investigation of gene function specifically within the context of liver adenocarcinoma pathogenesis, providing a disease-relevant platform for functional genomics.
C15orf40 is an uncharacterized protein-coding gene with no validated molecular functions, interacting partners, or pathway memberships. No upstream regulators, downstream effectors, or associated signaling modules have been identified. Its expression profile, subcellular localization, and physiological roles remain unexplored, making this knockout model a valuable discovery tool. Researchers can employ unbiased functional screens to identify phenotypic consequences and, if phenotypes arise, use approaches like immunoprecipitation-mass spectrometry for interactome mapping or CRISPR-based modifier screens to uncover synthetic lethal interactions. The polyclonal nature additionally ensures that any observed phenotype is not an artifact of a single clone. This hypothesis-generating framework is ideal for genes with completely unknown biology.
In SK-HEP-1 liver adenocarcinoma cells, the C15orf40 knockout model offers a unique opportunity to probe unknown gene functions in hepatocarcinogenesis. The lack of prior knowledge means that any impacts on proliferation, migration, invasion, or drug sensitivity could reveal novel oncogenic or tumor-suppressive roles. Since no disease associations are established, this product supports exploratory studies that may connect C15orf40 to liver cancer biology and uncover new biomarkers or therapeutic targets. The polyclonal format enhances the detection of robust, population-level phenotypes that are more likely to translate to heterogeneous tumor environments.
This knockout product is well-suited for a broad panel of functional assays, including western blotting and RT-qPCR to confirm C15orf40 disruption, cell proliferation and colony formation assays to assess growth, and migration and invasion assays to evaluate metastatic behavior. Drug sensitivity profiling and flow cytometry further allow analysis of chemotherapeutic responses and apoptotic induction. Additionally, these polyclonal knockout cells can be integrated into high-throughput CRISPR screens or used for comparative transcriptomic and proteomic studies. For detailed protocols or technical support, please contact Ascent Research.
